logo

For the Inventor, By the Inventor

Paris, France

Biophytis

Calculating rank
USPTO Granted Patents = 8


Forward Citations = 3

Loading Chart...
Loading Chart...

23 inventors (with patents filed for the assignee):

goldMedal René Lafont (8 out of 10 patents)

silverMedal Stanislas Veillet (8 out of 10 patents)

bronzeMedal Pierre Dilda (4 out of 4 patents)

4.  Mathilde Latil (4 out of 6 patents)

5.  Jose-Alain Sahel (3 out of 44 patents)

6.  Waly Dioh (3 out of 4 patents)

7.  Sophie N Raynal (2 out of 6 patents)

8.  Jean-Denis Durand (2 out of 6 patents)

9.  Franck F Lepifre (2 out of 12 patents)

10.  Serge Camelo (2 out of 2 patents)

11.  Valerie Fontaine (1 out of 2 patents)

12.  Pierre-Paul Elena (1 out of 3 patents)

13.  Valérie Fontaine (1 out of 2 patents)

14.  Maria Serova (1 out of 1 patent)

15.  Onnik Agbulut (1 out of 1 patent)


8 patents:

1. 12551495 - Phytoecdysones and derivatives thereof for use in treating disordered respiratory function on viral infection (2026-02-17),
2. 12440500 - Phytoecdysones and the derivatives thereof for use in the treatment of neuromuscular diseases (2025-10-14),
3. 12215067 - Chemical compounds targeting the eye and use thereof in the treatment of eye diseases (2025-02-04),
4. 11542295 - Use of 20-hydroxyecdysone and the derivatives thereof in the treatment of myopathies (2023-01-03),
5. 10513503 - Use of 3-deoxyanthocyanidins for treating occular diseases (2019-12-24),
6. 10316056 - Chemical compounds and use thereof for improving muscular quality (2019-06-11),
7. 10314804 - Composition containing norbixin for protecting cells of the retinal pigment epithelium (2019-06-11),
8. 9938315 - Chemical compounds and use thereof for improving muscular quality (2018-04-10),
Company Overview
Biophytis is a clinical-stage biotechnology company developing drug candidates for age-related diseases. The company's focus is on developing therapeutics to slow down or alter the course of chronic diseases, such as sarcopenia and age-related macular degeneration. Biophytis' lead drug candidate is Sarconeos, which is currently in clinical trials for sarcopenia, a condition characterized by loss of muscle mass and strength.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

8 Patents

#417 in Paris

#2,028 in France

Paris, FR
Paris, France

Biophytis

Forward Citations = 3

23 inventors:

goldMedal René Lafont (8 out of 10 patents)

silverMedal Stanislas Veillet (8 out of 10 patents)

bronzeMedal Pierre Dilda (4 out of 4 patents)

4.  Mathilde Latil (4 out of 6 patents)

5.  Jose-Alain Sahel (3 out of 44 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biophytis. Retrieved from https://idiyas.com/company/biophytis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…